Can allergies cause hair loss? The answer is nuanced: whilst allergies rarely destroy hair follicles directly, they can trigger physiological responses — including chronic inflammation, immune dysregulation, and physical stress — that disrupt the normal hair growth cycle. Conditions such as scalp contact dermatitis, atopic eczema, and alopecia areata all have recognised links to allergic or immune-mediated pathways. This article explores the mechanisms behind allergy-related hair shedding, how it is diagnosed within the NHS, and the treatment options available to help you manage both conditions effectively.

How Allergies Can Contribute to Hair Loss

Allergies contribute to hair loss primarily through chronic inflammation and physical stress, which can push hair follicles prematurely into the telogen (resting) phase, causing a condition known as telogen effluvium rather than direct follicle destruction.

Not sure if this is normal? Chat with one of our pharmacists →

The relationship between allergies and hair loss is more nuanced than a simple cause-and-effect. In most cases, allergies do not directly destroy hair follicles, but they can trigger a cascade of physiological responses that may disrupt the normal hair growth cycle. Understanding this distinction is important for anyone noticing increased shedding alongside allergic symptoms.

One proposed mechanism involves chronic inflammation. When the immune system mounts an allergic response, it releases inflammatory mediators such as histamine, cytokines, and immunoglobulin E (IgE). Prolonged or repeated allergen exposure may sustain low-grade inflammation, which could interfere with the anagen (growth) phase of the hair cycle, pushing more hairs prematurely into the telogen (resting) phase — a condition known as telogen effluvium. It is important to note that the evidence linking mild or seasonal allergies directly to significant hair shedding remains modest; the indirect pathways are recognised in dermatological literature, but a formal causal link has not been established for most common allergic conditions.

Telogen effluvium typically becomes noticeable two to three months after the triggering event and is usually self-limiting once the underlying cause is addressed. Hair regrowth generally follows over subsequent months, though this varies between individuals.

The psychological and physical stress of managing a chronic allergic condition — such as severe eczema, allergic rhinitis, or asthma — can itself act as a trigger for hair shedding, as the body may redirect resources away from non-essential functions such as hair growth.

Some medicines used to manage other conditions can occasionally trigger telogen effluvium as a side effect. If you suspect a medicine is affecting your hair, do not stop taking it without speaking to your prescribing clinician first. Suspected side effects from any medicine should be reported to the MHRA via the Yellow Card Scheme (yellowcard.mhra.gov.uk). For further general information, the NHS provides a helpful overview of hair loss and its causes.

Experiencing these side effects? Our pharmacists can help you navigate them →

Types of Allergic Reactions Linked to Hair Shedding

Scalp contact dermatitis, alopecia areata, and atopic eczema affecting the scalp are the main allergy-related conditions linked to hair shedding, each acting through distinct but overlapping immune mechanisms.

Several distinct types of allergic and immune-mediated reactions have been associated with hair loss, each through slightly different mechanisms. Recognising which type may be involved can help guide appropriate investigation and treatment.

Contact dermatitis of the scalp is one of the most direct links. This occurs when the scalp is exposed to an allergen — commonly found in hair dyes (particularly paraphenylenediamine, or PPD), shampoos, conditioners, or topical treatments. The resulting inflammation can disrupt hair follicles in the affected area, leading to patchy or diffuse hair thinning. Importantly, this type of hair loss is typically non-scarring and reversible once the allergen is identified and avoided, and inflammation is treated. Patch testing is the gold-standard investigation for identifying the responsible allergen.

Alopecia areata is an autoimmune condition in which the immune system mistakenly attacks hair follicles, causing well-defined patches of hair loss. While it is not strictly an allergic condition, it shares immunological pathways with atopic diseases. Research has shown a higher prevalence of alopecia areata in individuals with atopic dermatitis, asthma, and allergic rhinitis, suggesting a shared immune dysregulation (NICE CKS: Alopecia areata).

Other relevant associations include:

• Atopic dermatitis (eczema) affecting the scalp, which can cause scratching-related hair breakage and follicular disruption

• Unsupervised elimination diets undertaken in response to suspected food allergies, which carry a risk of nutritional deficiencies (such as low iron or zinc) that may secondarily affect hair growth; dietitian input is strongly advised before restricting food groups

• Drug-induced telogen effluvium, where certain medicines can occasionally precipitate hair shedding; this is uncommon and usually reversible after the medicine is reviewed

It is also important to consider other causes of hair loss that may mimic allergy-related shedding. Tinea capitis (scalp ringworm), a fungal infection, is a key differential — particularly in children — and requires prompt diagnosis and treatment with systemic antifungals. Scarring alopecias (such as lichen planopilaris) are less common but can cause permanent hair loss if not identified and treated early; these require urgent specialist referral. Each of these possibilities underscores the importance of a thorough clinical history and examination when evaluating unexplained hair loss.

Diagnosing Allergy-Related Hair Loss in the UK

Diagnosis begins with a GP consultation and blood tests to exclude common causes such as anaemia and thyroid dysfunction, followed by patch testing for contact allergy or specialist referral for trichoscopy or scalp biopsy where indicated.

Diagnosing the precise cause of hair loss in the context of allergies requires a structured, stepwise approach. In the UK, initial assessment typically begins with a GP consultation, where a detailed history — including onset, pattern of hair loss, known allergies, medicines, and associated symptoms — is taken.

Blood tests are commonly requested to exclude other contributory causes. These may include:

• Full blood count (FBC) — to check for anaemia

• Ferritin (the preferred marker of iron stores; isolated serum iron is not routinely recommended)

• Thyroid function tests (TSH)

• Coeliac serology, if iron deficiency or gastrointestinal symptoms are present

• Vitamin D and B12 levels, where there is clinical suspicion of deficiency

• Inflammatory markers (CRP, ESR) if an autoimmune cause is suspected

If scalp contact allergy is suspected, a patch test — carried out by a dermatologist or specialist allergy clinic — is the most reliable method of identifying the offending allergen. The British Association of Dermatologists (BAD) and the British Society for Cutaneous Allergy (BSCA) recommend patch testing using a standard European baseline series, which includes PPD and common preservatives found in hair products.

Where a fungal infection such as tinea capitis is suspected — particularly in children or those with scaling, broken hairs, or lymphadenopathy — scalp scrapings and hair samples for mycology (microscopy and culture) should be taken before treatment is started (NICE CKS: Tinea capitis).

For suspected alopecia areata or other immune-mediated hair loss, a scalp biopsy may occasionally be performed to examine follicular architecture and inflammatory infiltrate. Trichoscopy (dermoscopy of the scalp) and the hair pull test are non-invasive tools increasingly used in specialist settings to assess hair and scalp conditions.

NICE guidance recommends that patients with significant or rapidly progressing hair loss, diagnostic uncertainty, suspected scarring alopecia, or suspected tinea capitis (especially in children) should be referred promptly to a dermatologist or appropriate specialist. Early and accurate diagnosis is key to preventing unnecessary or ineffective treatments.

Treatment Options Available on the NHS

NHS treatment depends on the underlying cause and ranges from allergen avoidance and topical corticosteroids for contact dermatitis to NICE-approved baricitinib for severe alopecia areata in eligible adults under specialist supervision.

Treatment for allergy-related hair loss on the NHS depends on the underlying cause identified during investigation. There is no single universal approach, and management is tailored to the specific mechanism involved.

For contact dermatitis of the scalp, the cornerstone of treatment is allergen avoidance — identifying and eliminating the offending product. Topical corticosteroids (such as betamethasone valerate scalp application) may be prescribed to reduce inflammation and support follicular recovery; these should be used at the lowest effective potency for the shortest necessary duration, as directed by your clinician (see the UK SmPC for betamethasone valerate scalp application, available via the MHRA/eMC). In most cases, hair regrowth occurs once the allergen is removed and inflammation resolves, though this can take several months.

For alopecia areata, the BAD and NICE outline several treatment options depending on the extent of hair loss:

• Potent topical corticosteroids are first-line for limited patchy alopecia areata

• Intralesional corticosteroid injections (triamcinolone acetonide) may be offered in specialist settings for persistent patches

• Topical immunotherapy with diphencyprone (DPCP) is an unlicensed, specialist-only therapy available in some NHS dermatology centres for extensive disease

• Baricitinib (Olumiant), a JAK inhibitor, is MHRA-licensed and has been recommended by NICE (NICE TA878) for severe alopecia areata in adults who meet defined clinical criteria. It is prescribed under specialist supervision only, with regular monitoring for serious risks including infections, venous thromboembolism (VTE), major adverse cardiovascular events (MACE), and malignancy, as detailed in the UK SmPC (available via the MHRA/eMC). It is not appropriate for all patients and is not a first-line treatment.

For tinea capitis, treatment is with systemic antifungals (such as griseofulvin or terbinafine, depending on the causative organism and patient age) and should be guided by a specialist, particularly in children.

For hair loss secondary to telogen effluvium triggered by allergic stress or nutritional deficiency, addressing the root cause — through allergy management, dietary correction, or stress reduction — is the primary intervention. NHS dietitians can provide support where nutritional deficiencies are identified. Hair loss associated with a medicine should be discussed with the prescribing clinician, as dose adjustment or switching may be appropriate; do not stop prescribed medicines without medical advice. Suspected adverse drug reactions should be reported via the MHRA Yellow Card Scheme.

When to See a GP or Dermatologist

See your GP promptly if you notice sudden or rapidly progressing hair loss, well-defined bald patches, scalp scaling or pustules, or hair loss following a new medicine or product, as early assessment can prevent irreversible follicle damage.

Knowing when to seek professional advice is important, as early intervention can prevent further hair loss and address any underlying conditions that may require treatment. Not all hair shedding warrants urgent concern — it is normal to lose between 50 and 100 hairs per day (NHS: Hair loss overview) — but certain signs should prompt a consultation.

Contact your GP promptly if you notice:

• Sudden or rapidly progressing hair loss over a period of weeks

• Well-defined bald patches on the scalp, beard, or eyebrows

• Scalp redness, scaling, itching, soreness, pustules, or pain that does not resolve with over-the-counter treatments

• Broken hairs, scaling, or lymph node swelling near the scalp — particularly in children — which may suggest tinea capitis

• Hair loss accompanied by other symptoms such as fatigue, weight changes, or joint pain, which may suggest a systemic condition

• Hair loss following a new medicine, hair product, or dietary change

• Significant emotional distress related to hair loss

Seek urgent or early specialist referral if:

• Scarring alopecia is suspected (scalp pain, pustules, or rapidly progressive permanent hair loss) — early treatment is essential to prevent irreversible follicle damage

• Tinea capitis is suspected, especially in children, as systemic antifungal treatment is required

• Alopecia areata is spreading rapidly or is associated with nail changes

• The diagnosis remains unclear after initial GP assessment

Your GP may manage straightforward cases directly or refer you to an NHS dermatology service for specialist assessment. In some cases, referral to an allergy clinic may also be appropriate, particularly if contact allergy or atopic disease is suspected.

Some private dermatology and trichology services offer faster access to patch testing and trichoscopy, which may be relevant for those experiencing significant distress or diagnostic uncertainty. However, NHS pathways remain the recommended first point of contact, ensuring that serious underlying causes are not overlooked. Do not self-diagnose or self-treat with unregulated supplements or topical products without professional guidance, as some may worsen scalp inflammation or interact with prescribed treatments.

Managing Both Allergies and Hair Loss Long-Term

Long-term management centres on effective allergy control, using hypoallergenic scalp care products, ensuring adequate nutrition, and regular GP or dermatologist follow-up to adjust treatment plans and support psychological wellbeing.

Living with both allergic conditions and hair loss can be challenging, but a proactive, integrated approach to management can significantly improve quality of life and outcomes. Long-term management focuses on controlling the underlying allergic disease, protecting the scalp, and supporting overall health.

Effective allergy control is central to reducing the indirect triggers of hair loss. For individuals with atopic dermatitis, adherence to an emollient-based skincare routine and appropriate use of topical anti-inflammatory treatments — including dupilumab, where recommended by NICE for eligible patients (see relevant NICE Technology Appraisals for adults and children) under specialist supervision — can help reduce systemic inflammatory burden. For allergic rhinitis, regular use of intranasal corticosteroids and non-sedating antihistamines helps manage symptoms effectively (NICE CKS: Allergic rhinitis).

From a scalp care perspective, individuals prone to contact allergy should:

• Choose fragrance-free, hypoallergenic hair care products

• Avoid hair dyes containing PPD; note that some PPD-free alternatives may contain cross-reacting chemicals, so formal patch testing by a dermatologist is advisable before switching products

• Minimise heat styling and chemical treatments that can further stress the scalp

Nutritional support plays an important supporting role. A balanced diet rich in iron, zinc, and protein provides the building blocks for healthy hair growth. Where deficiencies are confirmed on blood testing, supplementation under medical supervision may be recommended. Biotin (vitamin B7) supplementation is not routinely recommended unless a deficiency has been confirmed, as deficiency is rare in people eating a varied diet. Importantly, the MHRA has warned that high-dose biotin supplements can interfere with a range of laboratory tests, potentially causing falsely abnormal results; always inform your clinician if you are taking biotin before having blood tests.

If you suspect a nutritional deficiency related to a restricted diet or food allergy management, seek input from an NHS dietitian before making significant dietary changes.

Finally, the psychological impact of hair loss should not be underestimated. NHS Talking Therapies and support organisations such as Alopecia UK offer valuable resources for those struggling with the emotional aspects of hair loss. Regular follow-up with a GP or dermatologist ensures that treatment plans are reviewed and adjusted as needed, supporting both physical and emotional wellbeing over the long term.

Frequently Asked Questions